Acuity Brands Inc. (0H90)
London Exchange · UK · prices in USD · close of 23 Oct 2026
Key indicators
| Last close | USD 317.68 |
|---|---|
| 52-week range | 258.66 – 382.79 |
| Return, 1 month / 3 months | +2.8% / −2.0% |
| Return, 1 year / 3 years | −11.0% / +89.6% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 57 |
| Volatility (1 year) | 39.9% |
| Worst drawdown (1 year) | -31.3% |
| Average daily value traded | 0.01M USD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Acuity Brands is an American lighting company based in Atlanta, Georgia. It designs and makes indoor and outdoor lighting fixtures, including light-emitting diode luminaires, along with lighting controls and building management systems. Its products serve commercial, industrial, institutional and residential customers, and its brands include Lithonia Lighting and Holophane. The company also provides related services such as lighting design support and networked control solutions for buildings and outdoor spaces.
On this site Acuity Brands Inc. appears as a stock on the London Exchange (UK), code 0H90, with prices in US dollars (USD). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Acuity Brands Inc. (0H90) trades on the London Exchange in UK. It last closed at USD 317.68 on 23 October 2026.
Its price-based Market X-Ray is 43 out of 100 (a weak price profile), ranking 2,441 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 11.0% and over the last three months it fell 2.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 55 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 1.7% | ||
| From 52-week high | -16.1% | ||
| Momentum | 48 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -2.0% | ||
| 6-month return | 10.5% | ||
| 12-month return, skipping the last month | -13.5% | ||
| Stability (higher is calmer) | 43 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 39.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -31.3% | ||
| Liquidity | 15 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.01M USD | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 4 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +5.5% |
|---|---|
| 1 month | +2.8% |
| 3 months | −2.0% |
| 6 months | +10.5% |
| 1 year | −11.0% |
| 3 years | +89.6% |
| 5 years | +51.9% |
Signals
| 50-day / 200-day average | 318.97 / 312.52 |
|---|---|
| Golden / death cross (60 days) | Golden, 56 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 11.02 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 16 Oct 2025 | USD 0.1700 |
| 18 Jul 2025 | USD 0.1700 |
| 17 Apr 2025 | USD 0.1700 |
| 3 Feb 2025 | USD 0.1700 |
| 18 Oct 2024 | USD 0.1500 |
| 18 Jul 2024 | USD 0.1500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.